BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6295430)

  • 1. Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
    Skinner GR; Buchan A; Williams D; Marsden J; Hartley C; Wilbanks G; Turyk M; Namkoong ES
    Br J Exp Pathol; 1982 Aug; 63(4):378-87. PubMed ID: 6295430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.
    Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J
    Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
    Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
    Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
    Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
    Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for control of herpes simplex virus disease through immunization.
    Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
    Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal studies on the efficacy of vaccination against recurrent herpes.
    Scriba M
    Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
    Harney BA; Easty DL; Skinner GR
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus vaccines.
    Meignier B; Roizman B
    Antiviral Res; 1985; Suppl 1():259-65. PubMed ID: 3002260
    [No Abstract]   [Full Text] [Related]  

  • 13. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance of chicks to Herpes simplex virus].
    Cassai E; Menarini L; Corradini L
    Boll Ist Sieroter Milan; 1972; 51(3):173-6. PubMed ID: 4347184
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-immunological aspects of recurrent herpes simplex during vaccine therapy].
    Semenova TB; Karpovich LG; Barinskiĭ IF; Blokha VV; Kalashnikova TV
    Vestn Dermatol Venerol; 1988; (7):49-53. PubMed ID: 2851233
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody reactivity with Skinner HSV vaccine.
    Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
    Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital herpes.
    Oates JK
    Br J Hosp Med; 1983 Jan; 29(1):13-22. PubMed ID: 6297643
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
    Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
    Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral infection of newborn guinea pigs with herpes simplex virus type 1.
    Blaskovic D; Svobodová J; Weidnerová K; Stastný B
    Acta Virol; 1971 Nov; 15(6):522. PubMed ID: 4400435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.